Recon: Novavax falls on reports of production delays; Biogen's Aduhelm sales fall well below expectations
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy